T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
Global Payments
GPN
|
+$2B |
| 3 |
NextEra Energy
NEE
|
+$1.82B |
| 4 |
Salesforce
CRM
|
+$1.51B |
| 5 |
Boeing
BA
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.43B |
| 5 |
Elevance Health
ELV
|
+$1.39B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
CAE Inc. Common Shares
CAE
$8.47B
| $45.9M | 0.01% |
1,804,863
-150
| -0% | -$3.94K |
|
902
Datadog
DDOG
$90.6B
| $45.9M | 0.01% |
+1,352,700
| New | +$47M |
|
|
TPTX
903
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $45.7M | 0.01% |
1,214,857
+324,807
| +36% | +$14.1M |
|
|
HONE
904
DELISTED
HarborOne Bancorp
HONE
| $45.7M | 0.01% |
4,538,142
+2,628,393
| +138% | +$27.1M |
|
905
Emergent Biosolutions
EBS
$230M
| $45.5M | 0.01% |
870,528
+57,295
| +7% | +$2.67M |
|
|
HCCI
906
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $45.3M | 0.01% |
1,708,666
+10,448
| +0.6% | +$272K |
|
907
Kirby Corp
KEX
$7.26B
| $45.1M | 0.01% |
549,423
-1,520
| -0.3% | -$116K |
|
|
ANSS
908
DELISTED
Ansys
ANSS
| $45M | 0.01% |
203,486
+1,856
| +0.9% | +$391K |
|
909
AtriCure
ATRC
$2.21B
| $45M | 0.01% |
1,803,174
+111,682
| +7% | +$3.19M |
|
910
Virtus Investment Partners
VRTS
$1.14B
| $44.9M | 0.01% |
405,863
-257
| -0.1% | -$27.6K |
|
|
DHR.PRA
911
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $44.6M | 0.01% |
39,210
| – | – |
|
|
CMD
912
DELISTED
Cantel Medical Corporation
CMD
| $44.5M | 0.01% |
595,435
-3,288
| -0.5% | -$279K |
|
913
Brown-Forman Class B
BF.B
$12.9B
| $44.1M | 0.01% |
702,597
+49,687
| +8% | +$2.9M |
|
|
HZNP
914
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $44M | 0.01% |
1,615,030
+513,282
| +47% | +$13.3M |
|
915
LyondellBasell Industries
LYB
$20.2B
| $44M | 0.01% |
491,358
-93,237
| -16% | -$7.6M |
|
916
Murphy USA
MUSA
$10.4B
| $43.9M | 0.01% |
514,885
+18,992
| +4% | +$1.67M |
|
917
Qualys
QLYS
$6.78B
| $43.4M | 0.01% |
574,937
-10,417
| -2% | -$868K |
|
918
Cactus
WHD
$5.78B
| $43.4M | 0.01% |
1,500,649
+782,679
| +109% | +$22.6M |
|
|
EVOP
919
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $43.4M | 0.01% |
1,542,199
+37,931
| +3% | +$1.11M |
|
920
American Airlines Group
AAL
$9.97B
| $43.2M | 0.01% |
1,602,506
+9,928
| +0.6% | +$291K |
|
921
Vistra
VST
$49.1B
| $43M | 0.01% |
1,609,480
-4,456,621
| -73% | -$106M |
|
922
Saic
SAIC
$5.35B
| $43M | 0.01% |
492,242
-1,502
| -0.3% | -$128K |
|
923
PENN Entertainment
PENN
$2.53B
| $42.9M | 0.01% |
2,304,205
+281,883
| +14% | +$5.34M |
|
924
Parker-Hannifin
PH
$134B
| $42.8M | 0.01% |
237,148
-4,666
| -2% | -$794K |
|
925
Globus Medical
GMED
$11.5B
| $42.6M | 0.01% |
833,659
+46,659
| +6% | +$2.22M |
|
Similar funds
T. Rowe Price Associates's Q3 2019 Portfolio in Review
As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
- T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
- T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
- T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
- T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
- T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.
Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.